Increased T-bet/GATA-3 and ROR-γt /Foxp3 Ratios in Cerebrospinal Fluid as Potential Criteria for Definite Neuro-Behçet's Disease.
PBMCs
ROR-γt/Foxp3
T-bet/GATA-3
cerebrospinal fluid
neuro-Behçet’s disease
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
29 Jul 2022
29 Jul 2022
Historique:
received:
19
05
2022
revised:
27
06
2022
accepted:
01
07
2022
entrez:
12
8
2022
pubmed:
13
8
2022
medline:
13
8
2022
Statut:
epublish
Résumé
When the central nervous system (CNS) is the primary affected site in an initial attack of Behçet's disease (BD), the differential diagnosis is particularly challenging. Some cases remain unclassified or qualified as probable neuro-Behçet's disease (NBD). Several cytokines are involved in the immunopathogenesis of this disease; however, studies establishing the differential cytokine pattern between probable and definite NBD are scarce. Twenty-eight parenchymal NBD patients, diagnosed according to the International Consensus Recommendation (ICR) criteria and classified into definite (D-NBD;
Identifiants
pubmed: 35956031
pii: jcm11154415
doi: 10.3390/jcm11154415
pmc: PMC9369407
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Tunisian Ministry for Higher Education, Research, and Technology
ID : LR16/IPT/02
Références
Scand J Immunol. 2006 Dec;64(6):655-60
pubmed: 17083622
Clin Immunol Immunopathol. 1997 Jan;82(1):12-7
pubmed: 9000037
Neurology. 2017 Mar 28;88(13):1218-1225
pubmed: 28235811
J Neurol Sci. 2015 Feb 15;349(1-2):143-8
pubmed: 25601769
Cell Mol Immunol. 2014 Nov;11(6):613-6
pubmed: 24909741
J Inflamm Res. 2011;4:139-46
pubmed: 22259252
Clin Neurol Neurosurg. 2013 Oct;115(10):2015-8
pubmed: 23830180
J Neuroimmunol. 2003 Dec;145(1-2):127-34
pubmed: 14644038
J Neurol Neurosurg Psychiatry. 2003 May;74(5):608-13
pubmed: 12700303
Brain. 1999 Nov;122 ( Pt 11):2171-82
pubmed: 10545401
Front Genet. 2021 Feb 26;12:638236
pubmed: 33719347
Cytokine. 2020 Mar 6;130:155054
pubmed: 32151963
Cytokine. 2018 Aug;108:160-167
pubmed: 29625335
Ann Neurol. 2017 Aug;82(2):288-298
pubmed: 28749553
J Neurol Sci. 1999 Nov 30;170(2):105-11
pubmed: 10561525
Brain. 1999 Nov;122 ( Pt 11):2183-94
pubmed: 10545402
Clin Exp Rheumatol. 1992 Nov-Dec;10(6):599-602
pubmed: 1483312
Arch Neurol. 1989 Mar;46(3):265-9
pubmed: 2919979
Invest Ophthalmol Vis Sci. 2008 Jul;49(7):3058-64
pubmed: 18579762
J Neurol Sci. 1998 Aug 14;159(2):181-5
pubmed: 9741405
J Neurol. 2014 Sep;261(9):1662-76
pubmed: 24366648
Handb Clin Neurol. 2014;121:1703-23
pubmed: 24365442
AJNR Am J Neuroradiol. 1999 Jun-Jul;20(6):1015-24
pubmed: 10445437
Rev Med Interne. 2006 Oct;27(10):742-50
pubmed: 16987570
Mod Rheumatol. 2012 Jun;22(3):405-13
pubmed: 21935641
J Dermatol. 2003 Aug;30(8):602-7
pubmed: 12928529
J Clin Med. 2017 Jul 21;6(7):
pubmed: 28753995
Angew Chem Int Ed Engl. 2012 Oct 1;51(40):10118-22
pubmed: 22961978
Int J Dermatol. 2003 May;42(5):346-51
pubmed: 12755969
Tohoku J Exp Med. 1980 Dec;132(4):421-30
pubmed: 6167023
AJNR Am J Neuroradiol. 2011 Jun-Jul;32(6):1050-5
pubmed: 21511865
Arch Neurol. 2005 Jun;62(6):865-70
pubmed: 15956157
Clin Neurol Neurosurg. 2009 Jul;111(6):507-10
pubmed: 19303205
Eur J Neurol. 2007 Feb;14(2):174-80
pubmed: 17250726
Clin Rheumatol. 2010 Nov;29(11):1211-6
pubmed: 20495938
Clin Exp Rheumatol. 2013 May-Jun;31(3 Suppl 77):25-7
pubmed: 23558092
Lancet Neurol. 2009 Feb;8(2):192-204
pubmed: 19161910
Ann Clin Transl Neurol. 2018 Mar 10;5(4):493-498
pubmed: 29687026
Intern Med. 2012;51(24):3359-65
pubmed: 23257520
Exp Mol Pathol. 2003 Feb;74(1):17-22
pubmed: 12645628
J Neurol Neurosurg Psychiatry. 1998 Mar;64(3):382-4
pubmed: 9527155
J Neurol Neurosurg Psychiatry. 1994 Aug;57(8):897-902
pubmed: 8057110
Cytokine. 2008 Dec;44(3):373-6
pubmed: 19010690